---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-083043"
form_type: "8-K"
ticker: "BEAM"
cik: "0001745999"
company_name: "Beam Therapeutics Inc."
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T18:29:05.144762+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Beam Therapeutics shareholders elect directors, ratify Deloitte, approve say-on-pay

## Summary
- Elected Mark Fishman (61.9M for, 10.3M against), Carole Ho (71.7M for), and Kathleen Walsh (71.9M for) as Class II directors.
- Ratified Deloitte & Touche as independent auditor for FY2025 with 84.3M for, 154K against, 63.6K abstentions.
- Advisory vote on named executive officer compensation approved: 71.7M for, 562.9K against, 33.9K abstentions.
- All proposals passed; broker non-votes were 12.2M on director elections and say-on-pay.

## SEC filing metadata
- accession: 0000950170-25-083043
- form_type: 8-K
- ticker: BEAM
- cik: 0001745999
- company_name: Beam Therapeutics Inc.
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1745999/000095017025083043/0000950170-25-083043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1745999/000095017025083043/beam-20250604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-083043
- JSON: https://secwatch.observer/filing/0000950170-25-083043.json
- Plain text: https://secwatch.observer/filing/0000950170-25-083043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.